Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: August 24, 2005
Last updated: September 22, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2006
  Estimated Primary Completion Date: No date given